Imparta’s Michelle Vazzana to Lead Breakthrough AI Sales Workshop at LTEN 2025

June 2025 | News

Imparta is proud to announce that Michelle Vazzana, Chief Innovation Officer, has been selected to present an exclusive workshop at the 2025 LTEN Annual Conference, taking place July 28–31 at the Gaylord Rockies in Aurora, Colorado. Her workshop was chosen from among hundreds of applications, reflecting the critical relevance of her session to today’s rapidly evolving Life Sciences and MedTech sales environments.

The LTEN Annual Conference is a cornerstone event for life sciences learning and development professionals. With over 70 interactive workshops, 1,000+ attendees, and cutting-edge discussions across biotech, pharmaceutical, medical device, and diagnostics sectors, LTEN 2025 promises to be a transformative experience.

Michelle Vazzana, Chief Innovation Officer at Imparta, said, “We’re witnessing an inflextion point where artificial intelligence is rapidly reshaping how sales professionals operate, especially in highly regulated environments like life sciences and MedTech. While the promise of AI is tremendous, so too are the risks, particularly around compliance, data privacy, and content accuracy.

Sales teams are being asked to do more with less, move faster, and personalise at scale, all while navigating a maze of regulations. What they need isn’t just theoretical understanding; they need real-world, actionable frameworks they can apply immediately to stay competitive and compliant. That’s exactly what this session offers: a hands-on, strategic approach to integrating AI into the sales process responsibly and effectively.”

Michelle’s interactive, hands-on session will equip life sciences sales professionals to harness the power of AI for prospecting, engagement, and deal execution, while remaining firmly within regulatory and compliance boundaries such as HIPAA, GDPR, and industry-specific frameworks.

Attendees will learn how to:

• Leverage AI tools for sales tasks by identifying which to replace, augment, and enhance to maximise sales productivity.
• Use AI for prospecting in a compliant manner, extracting insights from clinical trials, journals, and regulatory approvals without violating data privacy laws.
• Generate personalised, compliant outreach using AI to craft email sequences, sales pitches, and stakeholder engagement plans.
• Assess AI-generated content for risks by spotting hallucinations, bias, and compliance violations in AI-generated messaging.
• Develop an AI-powered action plan tailored to their specific sales role, customer segment, and organisation’s compliance policies.

“Michelle’s selection to lead a session at LTEN 2025 is not only a testament to her expertise, but to the urgent need for innovation in our field,” said Claire Cologne, Imparta’s Global Head of Sales and former Co-Chair of the TT LifeSciences Medical Device Sales Training Conference. “The intersection of AI and compliance is one of the most complex and important challenges facing commercial teams today. What makes Michelle’s approach so powerful is that it’s grounded in the real-world pressures salespeople face daily. Her workshop will give attendees the clarity and confidence they need to harness AI effectively, without sacrificing the trust, rigour, and compliance that define successful selling in this industry.”

For sales professionals in pharmaceuticals, diagnostics, biotech, and medical devices, this workshop represents a unique opportunity to develop AI literacy, improve productivity, and navigate the compliance minefield that defines modern sales in healthcare.

To learn more and register for the event, visit: https://cvent.me/7ZN49L

If you would like to discuss any of the topics above or Imparta’s offerings, please contact us or call directly on +44 (0) 20 3743 3021 for our UK office, or +1 (516) 595 0020 to speak with our team in the US.